30 Dec 2018

BOSTON SCIENTIFIC ACQUIRING BTG

Boston Scientific has reached an agreement on the terms of a recommended offer to acquire BTG plc., a United Kingdom-based company that develops and commercializes products used in minimally-invasive procedures, targeting vascular diseases and cancer, as well as acute care pharmaceuticals. Under the terms of the transaction, holders of BTG’s

0
20 Dec 2018

MCAFEE: CRYPTOMINING AND IoT MALWARE BOTH ROSE OVER 70% IN Q3 2018

    By DeanTakahashi VentureBeat   Cybersecurity firm McAfee said that the cybercriminal underworld is generating 480 new threats per minute. That’s one of the details in the new McAfee Labs Threats Report: December 2018.   McAfee reported that internet of things malware was up 73 percent in the third quarter, while cryptocurrency

0
14 Dec 2018

VOLUNTARY MACRA CODES MAY DETERMINE WHAT DOCTORS ARE PAID

New patient relationship categories and codes are one of the most important provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), according to a piece in the New England Journal of Medicine. In January 2018, the billing-code modifiers, which allow clinicians to report their relationship to a patient at a

0
11 Dec 2018

INSURANCE OBSTACLES TO TREATMENT BAFFLE PATIENTS SUFFERING FROM VENOUS REFLUX

    “My veins are covered by insurance, right? But, the XYZ Insurance Co. representative said my varicose veins are a covered benefit on my insurance plan.”    By James White, MD How many times have these words been uttered by potential patients upon arrival to our vein clinics? Yet,

0
11 Dec 2018

VEIN911 CEO FORMS MANAGEMENT SERVICE FOR INDEPENDENT PRACTICES

    The CEO of Vein911 Vein Treatment Centers, 21-year cancer survivor and healthcare industry veteran Chris Pittman, MD, has launched Health Performance Specialists (HPS), a national Management Services Organization for independent physicians. HPS helps independent physicians compete, succeed and thrive in today’s medical practice environment. The organization is designed to disrupt current healthcare

0
11 Dec 2018

THE VTN REPORT FOR OCTOBER AND NOVEMBER 2018

  SACRAMENTO AREA VASCULAR/VEIN PRACTICE FOR SALE Sebastian Conti, MD, FACS is offering a vascular/vein practice for sale in the Sacramento, California, area near a hospital. Attractive lease, experienced employees, three exam rooms, in office operating room, surgical instruments, VNUS, vascular lab (with tech) EMR >2,000-patient database. Dr. Conti is

0
21 Nov 2018

BOSTON SCIENTIFIC ACQUIRING BTG

    Boston Scientific has reached an agreement on the terms of a recommended offer to acquire BTG plc., a United Kingdom-based company that develops and commercializes products used in minimally-invasive procedures, targeting vascular diseases and cancer, as well as acute care pharmaceuticals. Under the terms of the transaction, holders

0
20 Nov 2018

CVS-AETNA MERGER DELAYED AS NEW YORK, NEW JERSEY NEGOTIATE

The plan to get everyone together to close CVS’s $69 billion acquisition of Aetna before Thanksgiving didn’t work out. The closing was expected to be by Nov. 22 but has been delayed until two New York and New Jersey approve the merger. In a new financial filing Nov. 19, the

0
08 Nov 2018

VIVA 2018: BTG SENTRY BIOCONVERTIBLE IVC FILTER STUDY SHOWS FLAWLESS PERFORMANCE

  BTG plc highlighted the presentation of the two-year results for the SENTRY Trial at the Vascular Interventional Advances (VIVA) conference in Las Vegas. The prospective, multicenter trial of the BTG Sentry, the world’s first bioconvertible IVC filter, found that in addition to providing protection against pulmonary embolism (PE) during the

0
08 Nov 2018

U.S. HEALTHCARE AGENDA: ALL TALK, NO ACTION

By Drew Altman With a Democratic House, a Republican Senate and President Trump in the White House, get ready for two years of maneuvering but little progress on healthcare — unless you look beyond Washington.             What to watch: No new health legislation of any significance will pass in this Congress.

0